Gini et al (2019)2222 Gini G, Annibali O, Lupasco D, Bocci C, Tomarchio V, Sampaolo M, et al. Gonadal function recovery and fertility in women treated with chemo-and/or radiotherapy for Hodgkin's and non-Hodgkin lymphoma. Chemotherapy. 2019;64(01):36-41. Doi: 10.1159/000499535 https://doi.org/10.1159/000499535...
|
16–50 years old |
Hodgkin LymphomaNon-Hodgkin Lymphoma |
Chemotherapy+Radiotherapy |
EtoposideDoxorubicinCyclophosphamideVincristinePrednisoneBleomycin |
↑ Amenorrhea |
97 |
Shandley et al (2018)2323 Shandley LM, Fothergill A, Spencer JB, Mertens AC, Cottrell HN, Howards PP. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome. Fertil Steril. 2018;109(03):516-525.e1. Doi: 10.1016/j.fertnstert.2017.11.016 https://doi.org/10.1016/j.fertnstert.201...
|
20–35 years old |
Breast CancerLymphomasReproductive Tumor |
Chemotherapy |
— |
↓ AFC↓AMH |
1090 |
Sinha et al (2018)2424 Sinha N, Letourneau JM,Wald K, Xiong P, Imbar T, Li B, et al. Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer. J Assist Reprod Genet. 2018;35(10):1861-1868. Doi: 10.1007/s10815-018-1203-8 https://doi.org/10.1007/s10815-018-1203-...
|
24–43 years old |
Breast Cancer |
Chemotherapy |
TaxotereCyclophosphamideCarboplatinFluorouracilEpirubicin |
↓ AFC |
88 |
Al-Rawi et al (2018)2525 Al-Rawi SA, Saleh BO, Al-Naqqash MA. Serum anti-müllerian hormone levels in evaluation of chemotherapy effect on ovarian reserve in women with breast cancer. A follow-up study. Saudi Med J. 2018;39(07):733-735. Doi: 10.15537/smj.2018.7.21897 https://doi.org/10.15537/smj.2018.7.2189...
|
25–45 years old |
Breast Cancer |
Chemotherapy |
AnthracyclineCyclophosphamide |
↓AMH↓E2↑ LH |
58 |
Anderson et al (2018)2626 Anderson RA, Remedios R, Kirkwood AA, Patrick P, Stevens L, Clifton-Hadley L, et al. Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial. Lancet Oncol. 2018;19(10):1328-1337. Doi: 10.1016/ S1470-2045(18)30500-X https://doi.org/10.1016/...
|
18–45 years old |
Hodgkin Lymphoma |
Chemotherapy |
— |
↓AMH↓E2↑ FSH |
67 |
D'Avila et al (2017)2727 D'Avila AM, Capp E, Corleta HVE. Antral follicles count and anti- Müllerian hormone levels after gonadotoxic chemotherapy in patients with breast cancer: cohort study. Rev Bras Ginecol Obstet. 2017;39(04):162-168. Doi: 10.1055/s-0037-1601438 https://doi.org/10.1055/s-0037-1601438...
|
27–40 years old |
Breast Cancer |
Chemotherapy |
Cyclophosphamide |
↑ Amenorrhea↑ FSH↓AMH↓ AFC↑E2
|
49 |
Chang et al (2017)2828 Chang X, Zhou L, Chen X, Xu B, Cheng Y, Sun S, et al. Impact of imatinib on the fertility of male patients with chronic myelogenous leukaemia in the chronic phase. Target Oncol. 2017;12(06): 827-832. Doi: 10.1007/s11523-017-0521-6 https://doi.org/10.1007/s11523-017-0521-...
|
15–51 years old |
Chronic Myeloid Leukemia |
Chemotherapy |
Imatinib |
↓ ejaculated volume↓Sperm↓ seminal density↓ Viability Sperm |
48 |
Creux et al (2017)2929 Creux H, Monnier P, Son WY, Tulandi T, Buckett W. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle inwomen with cancer who require urgent gonadotoxic treatment. Fertil Steril. 2017;107(01):198-204. Doi: 10.1016/j.fertnstert.2016.09.041 https://doi.org/10.1016/j.fertnstert.201...
|
16–40 years old |
Breast CancerCervical CancerHematological CancerGynecological CancerSarcomaGastrointestinal Cancer |
Chemotherapy |
— |
IVM - (normality) |
164 |
Wenners et al (2017)3030 Wenners A, Grambach J, Koss J, Maass N, Jonat W, Schmultzer A, Mundhenke C. Reduced ovarian reserve in young early breast cancer patients: preliminary data froma prospective cohort trial. BMC Cancer. 2017;17(01):632. Doi: 10.1186/s12885-017-3593-x https://doi.org/10.1186/s12885-017-3593-...
|
28–46 years old |
Breast Cancer |
Chemotherapy |
DocetaxelDoxorubicinFluorouracilCyclophosphamideEpirubicinPaclitaxelAnthracycline |
↓ ACF↓AMH↑ FSH↑ LH |
51 |
Perdrix et al (2017)3131 Perdrix A, Saint-Ghislain M, Degremont M, et al. Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer. Reprod Biomed Online. 2017;35(04):468-474. Doi: 10.1016/j.rbmo.2017.06.005 https://doi.org/10.1016/j.rbmo.2017.06.0...
|
11–35 years old |
Breast Cancer |
Chemotherapy+Radiotherapy |
FluorouracilEpirubicinCyclophosphamideDocetaxel |
↓AMH |
5775 |
McLaughlin et al (2017)3232 McLaughlin M, Kelsey TW, Wallace WH, Anderson RA, Telfer EE. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary. Hum Reprod. 2017;32(01):165-174. Doi: 10.1093/humrep/dew260 https://doi.org/10.1093/humrep/dew260...
|
12–30 years old |
Hodgkin Lymphoma |
Chemotherapy |
AdriamicinaBleomycinVinblastineDacarbazineVincristineEtoposidePrednisoneDoxorubicinCyclophosphamide |
↓ Follicular density↓ Follicular development |
13 |
Abir et al (2016)3333 Abir R, Ben-Aharon I, Garor R, et al. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy. Hum Reprod. 2016;31(04):750-762. Doi: 10.1093/humrep/dew007 https://doi.org/10.1093/humrep/dew007...
|
5–18 years old |
MedulloblastomaAcute Myeloid LeukemiaRhabdomyosarcomaEwing SarcomaHodgkin LymphomaOsteosarcoma |
Chemotherapy |
— |
↑ Number of atretic follicles↓ Oocyte maturation |
20 |
Hamy et al (2016)3434 Hamy AS, Porcher R, Eskenazi S, Cuvier C, Giacchetti S, Coussy F, et al. Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies. Reprod Biomed Online. 2016;32(03):299-307. Doi: 10.1016/j.rbmo.2015.12.008 https://doi.org/10.1016/j.rbmo.2015.12.0...
|
26–43 years old |
Breast Cancer |
Chemotherapy |
— |
↓AMH |
134 |
Paoli et al (2016)3535 Paoli D, Rizzo F, Fiore G, Pallotti F, Pulsoni A, Annechini G, et al. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens. Hum Reprod. 2016;31(02):263-272. Doi: 10.1093/ humrep/dev310 https://doi.org/10.1093/...
|
13–51 years old |
Hodgkin Lymphoma |
Chemotherapy |
DoxorubicinBleomycinVinblastineDacarbazine |
↓Sperm↑ Sperm anomalies |
810 |
Even-Or et al (2016)3636 Even-Or E, Ben-Haroush A, Yahel A, Yaniv I, Stein J. Fertility after treatment with high dose melphalan in women with acute myelogenous leukemia. Pediatr Blood Cancer. 2016;63(02): 334-336. Doi: 10.1002/pbc.25765 https://doi.org/10.1002/pbc.25765...
|
13 -36 years old |
Acute Myeloid Leukemia |
Chemotherapy |
Melfalano |
↓AMH↓ LH↓FSH |
35 |
Jacobson et al (2016)3737 Jacobson MH, Mertens AC, Spencer JB, Manatunga AK, Howards PP. Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all. Fertil Steril. 2016;105(03):765-772. e4. Doi: 10.1016/j.fertnstert.2015.11.020 https://doi.org/10.1016/j.fertnstert.201...
|
20–35 years old |
Breast CancerAcute Myeloid LeukemiaNon Hodgkin Lymphoma |
Chemotherapy+Radiotherapy |
— |
↑ Amenorrhea |
1282 |
Gupta et al (2016)3838 Gupta AA, Lee Chong A, Deveault C, Traubici J, Maloney AM, Knight S, et al. Anti-Müllerian hormone in female adolescent cancer patients before, during, and after completion of therapy: a pilot feasibility study. J Pediatr Adolesc Gynecol. 2016;29(06): 599-603. Doi: 10.1016/j.jpag.2016.04.009 https://doi.org/10.1016/j.jpag.2016.04.0...
|
11–18 years old |
OsteosarcomaHodgkin LymphomaB cell LymphomaDysgerminomaOsteosarcoma |
Chemotherapy |
CyclophosphamideDoxorubicinCisplatine |
↓AMH |
17 |
Ruddy et al (2015)3939 Ruddy KJ, Guo H, Barry W, Dang CT, Yardley DA, Moy B, et al. Chemotherapy-related amenorrhea after adjuvant paclitaxeltrastuzumab (APT trial). Breast Cancer Res Treat. 2015;151(03): 589-596. Doi: 10.1007/s10549-015-3426-z https://doi.org/10.1007/s10549-015-3426-...
|
40–45 years old |
Breast Cancer |
Chemotherapy |
TrastuzumabPaclitaxel |
↑ Amenorrhea |
410 |
Huser et al (2015)4040 Huser M, Smardova L, Janku P, Crha I, Zakova J, Stourac P, et al. Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analogues. J Assist Reprod Genet. 2015;32(08):1187-1193. Doi: 10.1007/s10815-015-0452-z https://doi.org/10.1007/s10815-015-0452-...
|
18–40 years old |
Hodgkin Lymphoma |
Chemotherapy |
AdriamycinBleomycinVinblastineVincristineProcarbazinePrednisoneEtoposideDoxorubicinCyclophosphamide |
↑ FSH |
108 |
Levi et al (2015)4141 Levi M, Hasky N, Stemmer SM, Shalgi R, Ben-Aharon I. Anti- Müllerian hormone is a marker for chemotherapy-induced testicular toxicity. Endocrinology. 2015;156(10):3818-3827. Doi: 10.1210/en.2015-1310 https://doi.org/10.1210/en.2015-1310...
|
20–44 years old |
Colon CancerEsophageal CancerThymic CancerRectal CancerNeck Cancer |
Chemotherapy |
CisplatineCapecitabineFluoropyrimidine |
↑ FSH↓Inhibin B↑ AMH |
20 |
Thomas-Teinturier et al (2015)4242 Thomas-Teinturier C, Allodji RS, Svetlova E, Frey M-A, Obertlin O, Millischer A-E, et al. Ovarian reserve after treatment with alkylating agents during childhood. Hum Reprod. 2015;30(06): 1437-1446. Doi: 10.1093/humrep/dev060 https://doi.org/10.1093/humrep/dev060...
|
18–39 years old |
Bone SarcomaSoft Tissue SarcomaNeuroblastomaHodgkin LymphomaNon Hodgkin LymphomaAcute Lymphoid Leukemia |
Chemotherapy+Radiotherapy |
CyclophosphamideIfosfamideProcarbazinebusulfan |
↑ FSH↓AMH |
105 |
Meissner et al (2015)4343 Meissner J, Tichy D, Katzke V, Kuhn T, Dietrich S, Schmitt T, et al. Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma. Ann Oncol. 2015;26(08):1771-1776. Doi: 10.1093/annonc/mdv227 https://doi.org/10.1093/annonc/mdv227...
|
18–40 years old |
Non Hodgkin Lymphoma |
Chemotherapy |
CyclophosphamideDoxorubicinVincristinePrednisone |
↑ Amenorrhea↓AMH |
46 |